1. Academic Validation
  2. Caspase-4 is required for activation of inflammasomes

Caspase-4 is required for activation of inflammasomes

  • J Immunol. 2012 Feb 15;188(4):1992-2000. doi: 10.4049/jimmunol.1101620.
Gabriel Sollberger 1 Gerhard E Strittmatter Magdalena Kistowska Lars E French Hans-Dietmar Beer
Affiliations

Affiliation

  • 1 Department of Biology, Institute of Cell Biology, ETH Zurich, CH-8093 Zurich, Switzerland.
Abstract

IL-1β and IL-18 are crucial regulators of inflammation and immunity. Both cytokines are initially expressed as inactive precursors, which require processing by the protease Caspase-1 for biological activity. Caspase-1 itself is activated in different innate immune complexes called inflammasomes. In addition, Caspase-1 activity regulates unconventional protein secretion of many other proteins involved in inflammation and repair. Human caspase-4 is a poorly characterized member of the Caspase family, which is supposed to be involved in endoplasmic reticulum stress-induced Apoptosis. However, its gene is located on the same locus as the Caspase-1 gene, which raises the possibility that caspase-4 plays a role in inflammation. In this study, we show that caspase-4 expression is required for UVB-induced activation of proIL-1β and for unconventional protein secretion by skin-derived keratinocytes. These processes require expression of the nucleotide-binding domain leucine-rich repeat containing, Pyrin domain containing-3 inflammasome, and caspase-4 physically interacts with its central molecule Caspase-1. As the active site of caspase-4 is required for activation of Caspase-1, the latter most likely represents a substrate of caspase-4. Caspase-4 expression is also essential for efficient nucleotide-binding domain leucine-rich repeat containing, Pyrin domain containing-3 and for absent in melanoma 2 inflammasome-dependent proIL-1β activation in macrophages. These results demonstrate an important role of caspase-4 in inflammation and innate immunity through activation of Caspase-1. Therefore, caspase-4 represents a novel target for the treatment of (auto)inflammatory diseases.

Figures